Literature DB >> 25418502

Evaluation of the toric implantable collamer lens for simultaneous treatment of myopia and astigmatism.

Marianne O Price1, Francis W Price.   

Abstract

Myopic astigmatism is a prevalent condition that can be treated with spectacles, contact lenses, or laser refractive surgery. However, these treatment options have functional limitations at higher levels of refractive error. The toric implantable collamer lens is designed to treat a broad range of refractive error, generally up to -18 diopters with +1 to +6 diopters of astigmatism. Approval for a more limited treatment range of up to 15 diopters of myopia with +1 to +4 diopters of astigmatism is being sought in the US, where this device has not yet received marketing approval. Surgical correction of high-myopic astigmatism can be life-altering and allow people to participate in activities that were not previously feasible because of visual limitations. The toric implantable collamer lens is implanted behind the iris and in front of the natural crystalline lens. With earlier lens designs, it was necessary to create an iridectomy or iridotomy to prevent pupillary block. The newest toric implantable collamer lens model has a small central hole that is not visually noticeable. This eliminates the need to create a hole in the iris, thereby enhancing the safety of the procedure.

Entities:  

Keywords:  astigmatism; keratoconus; myopia; pellucid marginal degeneration; phakic intraocular lens

Mesh:

Year:  2014        PMID: 25418502     DOI: 10.1586/17434440.2015.984685

Source DB:  PubMed          Journal:  Expert Rev Med Devices        ISSN: 1743-4440            Impact factor:   3.166


  4 in total

Review 1.  Meta-analysis and review: effectiveness, safety, and central port design of the intraocular collamer lens.

Authors:  Mark Packer
Journal:  Clin Ophthalmol       Date:  2016-06-09

2.  One-year natural course of corneal densitometry in high myopic patients after implantation of an implantable collamer lens (model V4c).

Authors:  Xun Chen; Yang Shen; Haipeng Xu; Xiaoying Wang; Xingtao Zhou
Journal:  BMC Ophthalmol       Date:  2020-02-12       Impact factor: 2.209

3.  Pure ICL Implantation: A Novel Ophthalmic Viscosurgical Device-Free Method.

Authors:  Qin Qin; Lianyun Bao; Zifang He; Feifei Chen; Dandan Zhu; Si Zhang; Wenwen Zhang; Yajun Liu; Ruiying Gao; Zhenggao Xie
Journal:  J Ophthalmol       Date:  2021-10-06       Impact factor: 1.909

4.  Comparison of white-to-white measurements using four devices and their determination of ICL sizing.

Authors:  Robert Edward T Ang; Edward Kenneth F Reyes; Fernando Amado J Ayuyao; Maria Isabel N Umali; Emerson M Cruz
Journal:  Eye Vis (Lond)       Date:  2022-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.